RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Mapping the epidemiology of Kaposi Sarcoma and Non-Hodgkin Lymphoma among children in Sub-Saharan Africa
A review
Rees, C. A., Keating, E. M., Lukolyo, H., Danysh, H. E., Scheurer, M. E., Mehta, P. S., Lubega, J., Slone, J. S., & Baylor Pediat HIV-Related (2016). Mapping the epidemiology of Kaposi Sarcoma and Non-Hodgkin Lymphoma among children in Sub-Saharan Africa: A review. Pediatric Blood and Cancer, 63(8), 1325-1331. https://doi.org/10.1002/pbc.26021
Children with human immunodeficiency virus (HIV) have an increased risk of developing Kaposi Sarcoma (KS) and non-Hodgkin lymphoma (NHL) compared to HIV-negative children. We compiled currently published epidemiologic data on KS and NHL among children in sub-Saharan Africa (SSA). Among countries with available data, the median incidence of KS was 2.05/100,000 in the general pediatric population and 67.35/100,000 among HIV-infected children. The median incidence of NHL was 1.98/100,000 among the general pediatric population, while data on NHL incidence among HIV-infected children were lacking. Larger regional studies are needed to better address the dearth of epidemiologic information on pediatric KS and NHL in SSA. (C) 2016 Wiley Periodicals, Inc.
